Stoke Therapeutics, Inc.
Pharmaceutical company · Bedford, Massachusetts, United States · Nasdaq: STOK
Stoke Therapeutics, Inc. is a pharmaceutical company headquartered in Bedford, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker STOK. It has reported private securities offerings to the US SEC, most recently $90 million sold in a notice filed in 2018.
Stoke Therapeutics at a glance
What does Stoke Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $90 million sold (2018).
Frequently asked questions about Stoke Therapeutics
Where is Stoke Therapeutics headquartered?
Stoke Therapeutics, Inc. is headquartered in Bedford, Massachusetts, United States.
What does Stoke Therapeutics do?
Stoke Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Stoke Therapeutics a public company?
Yes. Stoke Therapeutics, Inc. trades on Nasdaq under the ticker STOK.
When was Stoke Therapeutics founded?
The earliest incorporation on record for Stoke Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Ocular Therapeutix, IncBedford, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.